한국어
English
日本語
中文(简体)Spevigo (specolizumab)
450mg
Injections · Prescription medication
Boehringer Ingelheim Korea Ltd.
Specolizumab is an antibody treatment that regulates the excessive inflammatory response of the immune system.
MFDS ingredient code M283959
Specolizumab is a monoclonal antibody that targets specific inflammatory cytokine receptors. It is primarily used to modulate immune responses in autoimmune diseases or inflammatory conditions. It exhibits anti-inflammatory and immune-modulatory effects in pharmaceuticals.
Specolizumab inhibits excessive activation of immune cells by blocking signaling pathways that trigger inflammation. This reduces inflammatory responses and prevents tissue damage. Consequently, it helps the immune system function normally.
Approved uses differ by product. Check each product's information for its actual use.
Specolizumab is characterized by its selective binding to specific cytokine receptors. Unlike other immunomodulators, its clear target reduces side effects and allows for effective inflammation control. Therefore, it is classified as a drug specialized for the treatment of autoimmune diseases.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.